{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-016006","form_type":"8-K","ticker":"LIXT","cik":"0001335105","company_name":"LIXTE BIOTECHNOLOGY HOLDINGS, INC.","filed_at":"2023-05-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.489459+00:00","generated_at":"2026-06-15T06:03:45.223938+00:00","sec_items":["1.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Lixte terminates unused $10M at-the-market sales agreement with WestPark Capital","bullets":["Terminated ATM agreement dated Sept 20, 2021; no sales were ever made under it.","Agreement allowed sale of up to $10M of common stock through WestPark Capital.","Termination effective May 9, 2023; no financial impact or penalty noted."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-016006","json":"https://secwatch.observer/filing/0001493152-23-016006.json","markdown":"https://secwatch.observer/filing/0001493152-23-016006.md","text":"https://secwatch.observer/filing/0001493152-23-016006.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1335105/000149315223016006/0001493152-23-016006-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1335105/000149315223016006/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T06:03:45.223938+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"27f90ee3471ab0aa2e40e060ca3cf33be453b9c5","claim":"LIXTE BIOTECHNOLOGY HOLDINGS, INC. terminated Sales Agreement with WestPark Capital, Inc. valued at up to $10,000,000 (effective 2023-05-09).","evidence_excerpt":"Item 1.02 Termination of a Material Definitive Agreement. At-the-Market Sales Agreement Effective May 9, 2023, Lixte Biotechnology Holdings, Inc. (the “Company”) terminated the at-the-market sales agreement (the “Sales Agreement”), dated September 20, 2021, with WestPark Capital, Inc. (“WestPark Capital”) relating to the possible sale of up to $10,000,000 of shares of its common stock, from time to time, through WestPark Capital.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1335105/000149315223016006/0001493152-23-016006-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"termination"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"WestPark Capital, Inc."},{"label":"Value","value":"up to $10,000,000"},{"label":"Effective","value":"2023-05-09"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}